{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T19:11:34Z","timestamp":1787771494158,"version":"build-2784847793"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["annalsofvascularsurgery.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Vascular Surgery"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.avsg.2022.12.071","type":"journal-article","created":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T10:55:50Z","timestamp":1671274550000},"page":"257-265","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["A Systematic Review of Clopidogrel Resistance in Vascular Surgery: Current Perspectives and Future Directions"],"prefix":"10.1016","volume":"91","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8763-8813","authenticated-orcid":false,"given":"Young","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. Hope","family":"Weissler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neena","family":"Pack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher A.","family":"Latz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.avsg.2022.12.071_bib1","author":"Kane"},{"key":"10.1016\/j.avsg.2022.12.071_bib2","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/S0140-6736(96)09457-3","article-title":"A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee","volume":"348","author":"Committee","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.avsg.2022.12.071_bib3","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1056\/NEJMoa010746","article-title":"Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation","volume":"345","author":"Yusuf","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.avsg.2022.12.071_bib4","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.ehj.2003.10.013","article-title":"Expert consensus document on the use of antiplatelet agents. The task force on the use of antiplatelet agents in patients with atherosclerotic cardiovascular disease of the European society of cardiology","volume":"25","author":"Patrono","year":"2004","journal-title":"Eur Heart J"},{"key":"10.1016\/j.avsg.2022.12.071_bib5","doi-asserted-by":"crossref","first-page":"913","DOI":"10.2165\/00003088-200241120-00002","article-title":"Clinical significance of the cytochrome P450 2C19 genetic polymorphism","volume":"41","author":"Desta","year":"2002","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.avsg.2022.12.071_bib6","series-title":"FDA Drug Safety Communication: reduced effectiveness of Plavix (clopidogrel) in patients who are poor metabolizers of the drug","year":"2022"},{"key":"10.1016\/j.avsg.2022.12.071_bib7","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.jacc.2010.05.013","volume":"56","author":"Holmes","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.avsg.2022.12.071_bib8","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1001\/jama.2009.1232","article-title":"Association of cytochrome P450 2C19 genotype with the antiplatelet effect and clinical efficacy of clopidogrel therapy","volume":"302","author":"Shuldiner","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.avsg.2022.12.071_bib9","series-title":"UpToDate, Post TW (Ed), UpToDate","article-title":"Clopidogrel resistance and clopidogrel treatment failure","author":"Tantry","year":"2022"},{"key":"10.1016\/j.avsg.2022.12.071_bib10","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.avsg.2022.12.071_bib11","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.jvs.2013.09.011","article-title":"Platelet inhibition by adjunctive cilostazol suppresses the frequency of cerebral ischemic lesions after carotid artery stenting in patients with carotid artery stenosis","volume":"59","author":"Nakagawa","year":"2014","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.avsg.2022.12.071_bib12","doi-asserted-by":"crossref","first-page":"563","DOI":"10.2174\/1570161114666160714103148","article-title":"Clopidogrel high on-treatment platelet reactivity in patients with carotid artery stenosis undergoing endarterectomy. A pilot study","volume":"14","author":"Backovic","year":"2016","journal-title":"Curr Vasc Pharmacol"},{"key":"10.1016\/j.avsg.2022.12.071_bib13","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1007\/s00228-016-2094-1","article-title":"Impact of genetic polymorphisms related to clopidogrel or acetylsalicylic acid pharmacology on clinical outcome in Chinese patients with symptomatic extracranial or intracranial stenosis","volume":"72","author":"Zhao","year":"2016","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.avsg.2022.12.071_bib14","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1177\/1538574420947235","article-title":"Resistance to antiplatelet therapy is associated with symptoms of cerebral ischemia in carotid artery disease","volume":"54","author":"Ball","year":"2020","journal-title":"Vasc Endovascular Surg"},{"key":"10.1016\/j.avsg.2022.12.071_bib15","article-title":"Clopidogrel resistance is common in patients undergoing vascular and coronary interventions","author":"Berenson","year":"2022","journal-title":"Vascular"},{"key":"10.1016\/j.avsg.2022.12.071_bib16","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1177\/107602960300900204","article-title":"The effect of a loading dose (300 mg) of clopidogrel on platelet function in patients with peripheral arterial disease","volume":"9","author":"Matsagas","year":"2003","journal-title":"Clin Appl Thromb Hemost"},{"key":"10.1016\/j.avsg.2022.12.071_bib17","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ejvs.2006.01.013","article-title":"Variability in responsiveness to clopidogrel in patients with intermittent claudication","volume":"32","author":"Cassar","year":"2006","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.avsg.2022.12.071_bib18","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1007\/s00330-012-2441-2","article-title":"Management of peripheral arterial interventions with mono or dual antiplatelet therapy--the MIRROR study: a randomised and double-blinded clinical trial","volume":"22","author":"Tepe","year":"2012","journal-title":"Eur Radiol"},{"key":"10.1016\/j.avsg.2022.12.071_bib19","doi-asserted-by":"crossref","first-page":"151","DOI":"10.3109\/09537104.2012.676220","article-title":"Impaired responsiveness to clopidogrel and aspirin in patients with recurrent stent thrombosis following percutaneous intervention for peripheral artery disease","volume":"24","author":"Mazur","year":"2013","journal-title":"Platelets"},{"key":"10.1016\/j.avsg.2022.12.071_bib20","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1007\/s00270-013-0577-3","article-title":"Clopidogrel responsiveness in patients undergoing peripheral angioplasty","volume":"36","author":"Pastromas","year":"2013","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.avsg.2022.12.071_bib21","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1024\/0301-1526\/a000510","article-title":"High on-treatment platelet reactivity and outcomes after percutaneous endovascular procedures in patients with peripheral artery disease","volume":"45","author":"Bernlochner","year":"2016","journal-title":"Vasa"},{"key":"10.1016\/j.avsg.2022.12.071_bib22","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.ejvs.2016.04.019","article-title":"High on-treatment platelet reactivity in peripheral arterial disease: a pilot study to find the optimal test and cut off values","volume":"52","author":"Leunissen","year":"2016","journal-title":"Eur J Vasc Endovasc Surg"},{"issue":"5 Pt A","key":"10.1016\/j.avsg.2022.12.071_bib23","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.carrev.2017.10.013","article-title":"Prevalence of high on-treatment (aspirin and clopidogrel) platelet reactivity in patients with critical limb ischemia","volume":"19","author":"Clavijo","year":"2018","journal-title":"Cardiovasc Revasc Med"},{"key":"10.1016\/j.avsg.2022.12.071_bib24","first-page":"1308","article-title":"Aspirin and clopidogrel high on-treatment platelet reactivity and genetic predictors in peripheral arterial disease","volume":"91","author":"Yeo","year":"2018","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.avsg.2022.12.071_bib25","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.ejvs.2019.02.011","article-title":"CYP2C19 polymorphism is associated with amputation rates in patients taking clopidogrel after endovascular intervention for critical limb Ischaemia","volume":"58","author":"Lee","year":"2019","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.avsg.2022.12.071_bib26","first-page":"6065","article-title":"The correlation between platelet responsiveness to clopidogrel and CYP2C19 polymorphism in patients with peripheral vascular disease","volume":"25","author":"El-Khodary","year":"2021","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10.1016\/j.avsg.2022.12.071_bib27","first-page":"e686","article-title":"2016 AHA\/ACC guideline on the management of patients with lower extremity peripheral artery disease: executive summary: a report of the American College of cardiology\/American Heart association task force on clinical practice guidelines","volume":"135","author":"Gerhard-Herman","year":"2017","journal-title":"Circulation"},{"issue":"3 Suppl","key":"10.1016\/j.avsg.2022.12.071_bib28","first-page":"2S","article-title":"Society for Vascular Surgery practice guidelines for atherosclerotic occlusive disease of the lower extremities: management of asymptomatic disease and claudication","volume":"61","author":"Society for Vascular Surgery Lower Extremity Guidelines Writing","year":"2015","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.avsg.2022.12.071_bib29","doi-asserted-by":"crossref","first-page":"6408","DOI":"10.3390\/ijms21176408","article-title":"The phenomenon of clopidogrel high on-treatment platelet reactivity in ischemic stroke subjects: a comprehensive review","volume":"21","author":"Wisniewski","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.avsg.2022.12.071_bib31","doi-asserted-by":"crossref","first-page":"421","DOI":"10.4103\/0970-9185.117094","article-title":"Mapping the antiplatelet effects of clopidogrel and aspirin by modified thromboelastography","volume":"29","author":"Hemlata","year":"2013","journal-title":"J Anaesthesiol Clin Pharmacol"},{"key":"10.1016\/j.avsg.2022.12.071_bib32","doi-asserted-by":"crossref","first-page":"e19472","DOI":"10.1097\/MD.0000000000019472","article-title":"Association of clopidogrel high on-treatment reactivity with clinical outcomes and gene polymorphism in acute ischemic stroke patients: an observational study","volume":"99","author":"Fu","year":"2020","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.avsg.2022.12.071_bib33","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.jacc.2013.03.037","article-title":"The influence of smoking status on the pharmacokinetics and pharmacodynamics of clopidogrel and prasugrel: the PARADOX study","volume":"62","author":"Gurbel","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.avsg.2022.12.071_bib34","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1097\/MBC.0000000000000118","article-title":"High on-treatment platelet reactivity in patients with ischemic cerebrovascular disease: assessment of prevalence and stability over time using four platelet function tests","volume":"25","author":"Jover","year":"2014","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.avsg.2022.12.071_bib35","doi-asserted-by":"crossref","first-page":"e84","DOI":"10.1016\/j.jstrokecerebrovasdis.2012.07.012","article-title":"Prevalence of ex\u00a0vivo high on-treatment platelet reactivity on antiplatelet therapy after transient ischemic attack or ischemic stroke on the PFA-100((R)) and VerifyNow((R))","volume":"22","author":"Kinsella","year":"2013","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"10.1016\/j.avsg.2022.12.071_bib36","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.thromres.2013.12.002","article-title":"Clopidogrel high-on-treatment platelet reactivity in acute ischemic stroke patients","volume":"133","author":"Meves","year":"2014","journal-title":"Thromb Res"},{"key":"10.1016\/j.avsg.2022.12.071_bib37","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/j.jstrokecerebrovasdis.2015.01.004","article-title":"Predictive value of high residual platelet reactivity by flow cytometry for outcomes of ischemic stroke patients on clopidogrel therapy","volume":"24","author":"Qiu","year":"2015","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"10.1016\/j.avsg.2022.12.071_bib38","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1016\/j.jstrokecerebrovasdis.2017.04.012","article-title":"High on-treatment platelet reactivity to adenosine diphosphate predicts ischemic events of minor stroke and transient ischemic attack","volume":"26","author":"Rao","year":"2017","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"10.1016\/j.avsg.2022.12.071_bib39","doi-asserted-by":"crossref","first-page":"712","DOI":"10.3389\/fneur.2018.00712","article-title":"High on-treatment platelet reactivity in Danish hyper-acute ischaemic stroke patients","volume":"9","author":"Rath","year":"2018","journal-title":"Front Neurol"},{"key":"10.1016\/j.avsg.2022.12.071_bib40","doi-asserted-by":"crossref","first-page":"267","DOI":"10.3892\/etm.2014.2058","article-title":"Risk factors for clopidogrel resistance in patients with ischemic cerebral infarction and the correlation with ABCB1 gene rs1045642 polymorphism","volume":"9","author":"Su","year":"2015","journal-title":"Exp Ther Med"},{"key":"10.1016\/j.avsg.2022.12.071_bib41","doi-asserted-by":"crossref","first-page":"19900","DOI":"10.18632\/oncotarget.24945","article-title":"Response to clopidogrel is associated with early neurological deterioration after acute ischemic stroke","volume":"9","author":"Yi","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.avsg.2022.12.071_bib42","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/s00270-005-5288-y","article-title":"Dual antiplatelet regime versus acetyl-acetic acid for carotid artery stenting","volume":"29","author":"Dalainas","year":"2006","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.avsg.2022.12.071_bib43","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.ejvs.2005.01.012","article-title":"The benefits of combined anti-platelet treatment in carotid artery stenting","volume":"29","author":"McKevitt","year":"2005","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.avsg.2022.12.071_bib44","doi-asserted-by":"crossref","first-page":"e009727","DOI":"10.1161\/CIRCINTERVENTIONS.120.009727","article-title":"Antiplatelet therapy following peripheral arterial interventions: the choice is yours","volume":"13","author":"Aday","year":"2020","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.avsg.2022.12.071_bib45","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1016\/j.jacc.2006.11.044","article-title":"Variability in individual responsiveness to clopidogrel: clinical implications, management, and future perspectives","volume":"49","author":"Angiolillo","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.avsg.2022.12.071_bib46","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1016\/j.jacc.2005.07.056","article-title":"Clopidogrel effect on platelet reactivity in patients with stent thrombosis: results of the CREST Study","volume":"46","author":"Gurbel","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.avsg.2022.12.071_bib47","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1016\/j.jacc.2004.10.079","article-title":"Enhanced shear-induced platelet aggregation in patients who experience subacute stent thrombosis: a case-control study","volume":"45","author":"Ajzenberg","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.avsg.2022.12.071_bib48","first-page":"295","article-title":"Resistance to thienopyridines: clinical detection of coronary stent thrombosis by monitoring of vasodilator-stimulated phosphoprotein phosphorylation","volume":"59","author":"Barragan","year":"2003","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.avsg.2022.12.071_bib49","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1016\/j.jacc.2006.06.065","article-title":"Impact of the degree of peri-interventional platelet inhibition after loading with clopidogrel on early clinical outcome of elective coronary stent placement","volume":"48","author":"Hochholzer","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.avsg.2022.12.071_bib50","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1016\/j.jacc.2005.07.041","article-title":"Platelet reactivity in patients and recurrent events post-stenting: results of the PREPARE POST-STENTING Study","volume":"46","author":"Gurbel","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.avsg.2022.12.071_bib51","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.jacc.2006.10.050","article-title":"Increased risk in patients with high platelet aggregation receiving chronic clopidogrel therapy undergoing percutaneous coronary intervention: is the current antiplatelet therapy adequate?","volume":"49","author":"Bliden","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.avsg.2022.12.071_bib52","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1093\/eurheartj\/ehl275","article-title":"Low response to clopidogrel is associated with cardiovascular outcome after coronary stent implantation","volume":"27","author":"Geisler","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1016\/j.avsg.2022.12.071_bib53","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jacc.2005.08.058","article-title":"Aspirin and clopidogrel drug response in patients undergoing percutaneous coronary intervention: the role of dual drug resistance","volume":"47","author":"Lev","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.avsg.2022.12.071_bib54","first-page":"e166","volume":"113","author":"Smith","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.avsg.2022.12.071_bib55","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1016\/j.jacc.2006.06.049","article-title":"Benefit of a 600-mg loading dose of clopidogrel on platelet reactivity and clinical outcomes in patients with non-ST-segment elevation acute coronary syndrome undergoing coronary stenting","volume":"48","author":"Cuisset","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.avsg.2022.12.071_bib56","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.jacc.2006.04.090","volume":"48","author":"Montalescot","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.avsg.2022.12.071_bib57","doi-asserted-by":"crossref","first-page":"2946","DOI":"10.1161\/CIRCULATIONAHA.105.559088","volume":"112","author":"von Beckerath","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.avsg.2022.12.071_bib58","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1016\/j.jacc.2005.12.084","article-title":"Effect of clopidogrel with and without eptifibatide on tumor necrosis factor-alpha and C-reactive protein release after elective stenting: results from the CLEAR PLATELETS 1b study","volume":"48","author":"Gurbel","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.avsg.2022.12.071_bib59","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1161\/01.CIR.0000157138.02645.11","article-title":"Clopidogrel loading with eptifibatide to arrest the reactivity of platelets: results of the Clopidogrel Loading with Eptifibatide to Arrest the Reactivity of Platelets (CLEAR PLATELETS) study","volume":"111","author":"Gurbel","year":"2005","journal-title":"Circulation"}],"container-title":["Annals of Vascular Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890509622009025?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890509622009025?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:09:13Z","timestamp":1760188153000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0890509622009025"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":58,"alternative-id":["S0890509622009025"],"URL":"https:\/\/doi.org\/10.1016\/j.avsg.2022.12.071","relation":{},"ISSN":["0890-5096"],"issn-type":[{"value":"0890-5096","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Systematic Review of Clopidogrel Resistance in Vascular Surgery: Current Perspectives and Future Directions","name":"articletitle","label":"Article Title"},{"value":"Annals of Vascular Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.avsg.2022.12.071","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}